Clinicopathological study of recurrent uterine cervical squamous-cell carcinoma

Journal of Obstetrics and Gynaecology Research

Volumn 25, Issue 6, 1999, Pages 395-399

  Shiromizu, Kenji ^a   Kasamatsu, Takahiro ^a   Honma, Tomokazu ^a   Matsumoto, Koji ^a   Shirai, Takako ^a   Takahashi, Michiko ^a  

^a SAITAMA CANCER CENTER   (Japan)

Author keywords

Cervical carcinoma; Prognosis; Recurrence; Squamous cell carcinoma

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; CANCER RECURRENCE; FEMALE; HUMAN; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PROGNOSIS; RELAPSE; UTERINE CERVIX CARCINOMA;

EID: 0033400439     PISSN: 13418076     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1447-0756.1999.tb01183.x     Document Type: Article

References (11)

1. Piver MS, Chung WS. Prognostic significance of cervical lesion size and pelvic node metastases in cervical carcinoma. Obstet Gynecol 1975; 46: 507-510
2. Webb MJ, Symmonds RE. Site of recurrence of cervical cancer after radical hysterectomy. Am J Obstet Gynecol 1980; 138: 813-817
3. Fuller AF, Elliot N, Kosloff C, Lewis JL Jr. Lymph node metastases from carcinoma of the cervix, Stage IB and IIA: Implications for prognosis and treatment. Gynecol Oncol 1982; 13: 165-174
4. Shiromizu K, Matsuzawa M, Takahashi M, Ishihara O. Is postoperative radiotherapy or maintenance chemotherapy necessary for carcinoma of the uterine cervix? Br J Obstet Gynaecol 1988; 95: 503-506
5. Creasman WT. Editorial; New Gynecologic Cancer Staging. Gynecol Oncol 1995; 58: 157-158
6. Sobin LH, Wittekind Ch. eds. TMN Classification of Malignant Tumours 5th ed. New York · Chichester · Weinheim · Brisbane · Singapore · Toronto: Wiley-Liss, 1997
7. Shiromizu K, Ogawa M, Kamata H, Tominaga K, Koyama Y. Long-term mass-screening in uterine cervical carcinoma eradication strategy. Jpn J Clin Oncol 1990; 20: 134-138
8. the Harmsel B, van Muyden R, Smedts F, Hermans J, Knipers J, Raikhlin N, Petrov S, Lebedev A, Ramaekers F, Trimos B. The significance of cell type and tumor growth markers in the prognosis of unscreened cervical cancer patients. Int J Gynecol Cancer 1998; 8: 336-344
9. Shiromizu K, Ogawa M, Kotake K, Koyama Y, Nakazono M, Hirao K. Reconstruction of sigmoid vagina and conduit in total pelvic exenteration for recurrent cervical carcinoma. Jpn J Clin Oncol 1989; 19: 170-172
10. Shiromizu K, Kasamatsu T, Takahashi M, Kikuchi A, Yoshinari T, Matsuzawa M. Clinicopathological study of postoperative pulmonary metastasis of uterine cevical carcinoma. J Obstet Gynecol Res 1999; 25: 245-249
11. Ngan HYS, Cheng GTS, Cheng D, Wong LC, Ma HK. Post-treatment serial serum squamous cell carcinoma antigen (SCC) in the monitoring of squamous cell carcinoma of the cervix. Int J Gynecol Cancer 1996; 6: 115-119